Trial Profile
Multicenter study of [18F]-THK-5351 PET in tauopathies
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Feb 2020
Price :
$35
*
At a glance
- Drugs Fluorine 18 THK 5351 (Primary)
- Indications Tauopathies
- Focus Diagnostic use
- 30 Jan 2020 Status changed from recruiting to active, no longer recruiting.
- 12 Jul 2016 New trial record